{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:49:51Z","timestamp":1788173391273,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03979-7","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:34:17Z","timestamp":1774402457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of subanesthetic ketamine delivered via AmyloLipid nanovesicle (ALN)-based intranasal system on biobehavioral responses in an animal model of PTSD"],"prefix":"10.1038","volume":"16","author":[{"given":"Gal","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnon C.","family":"Sintov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Todder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4762-1969","authenticated-orcid":false,"given":"Hagit","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"3979_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edition) - DSM-5. 5 ed edn, (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"3979_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","volume":"49","author":"JH Krystal","year":"2024","unstructured":"Krystal JH, Kavalali ET, Monteggia LM. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms. Neuropsychopharmacology. 2024;49:41\u201350. https:\/\/doi.org\/10.1038\/s41386-023-01629-w.","journal-title":"Neuropsychopharmacology"},{"key":"3979_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol psychiatry. 2018;23:801\u201311. https:\/\/doi.org\/10.1038\/mp.2017.255.","journal-title":"Mol psychiatry"},{"key":"3979_CR4","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.14344.1","volume":"7","author":"RS Duman","year":"2018","unstructured":"Duman RS. Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide. F1000Research. 2018;7:F1000 https:\/\/doi.org\/10.12688\/f1000research.14344.1.","journal-title":"F1000Research"},{"key":"3979_CR5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","volume":"101","author":"JH Krystal","year":"2019","unstructured":"Krystal JH, Abdallah CG, Sanacora G, Charney DS, Duman RS. Ketamine: a paradigm shift for depression research and treatment. Neuron. 2019;101:774\u20138. https:\/\/doi.org\/10.1016\/j.neuron.2019.02.005.","journal-title":"Neuron"},{"key":"3979_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cct.2019.04.009","volume":"81","author":"CG Abdallah","year":"2019","unstructured":"Abdallah CG, Roache JD, Averill LA, Young-McCaughan S, Martini B, Gueorguieva R, et al. Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial. Contemporary Clin trials. 2019;81:11\u201318. https:\/\/doi.org\/10.1016\/j.cct.2019.04.009.","journal-title":"Contemporary Clin trials"},{"key":"3979_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105044","volume":"146","author":"M Asim","year":"2021","unstructured":"Asim M, Wang B, Hao B, Wang X. Ketamine for post-traumatic stress disorders and it\u2019s possible therapeutic mechanism. Neurochemistry Int. 2021;146:105044. https:\/\/doi.org\/10.1016\/j.neuint.2021.105044.","journal-title":"Neurochemistry Int"},{"key":"3979_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2174\/1570159x21666230428091433","volume":"22","author":"L Burback","year":"2024","unstructured":"Burback L, Br\u00e9mault-Phillips S, Nijdam MJ, McFarlane A, Vermetten E. Treatment of posttraumatic stress disorder: a state-of-the-art review. Curr Neuropharmacol. 2024;22:557\u2013635. https:\/\/doi.org\/10.2174\/1570159x21666230428091433.","journal-title":"Curr Neuropharmacol"},{"key":"3979_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1192\/bjp.bp.114.148551","volume":"206","author":"M Hoskins","year":"2015","unstructured":"Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, et al. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J psychiatry. 2015;206:93\u2013100. https:\/\/doi.org\/10.1192\/bjp.bp.114.148551.","journal-title":"Br J psychiatry"},{"key":"3979_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2022.113804","volume":"424","author":"WA Jumaili","year":"2022","unstructured":"Jumaili WA, Trivedi C, Chao T, Kubosumi A, Jain S. The safety and efficacy of ketamine NMDA receptor blocker as a therapeutic intervention for PTSD review of a randomized clinical trial. Behavioural brain Res. 2022;424:113804. https:\/\/doi.org\/10.1016\/j.bbr.2022.113804.","journal-title":"Behavioural brain Res"},{"key":"3979_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.euroneuro.2013.08.007","volume":"24","author":"A Juven-Wetzler","year":"2014","unstructured":"Juven-Wetzler A, Cohen H, Kaplan Z, Kohen A, Porat O, Zohar J. Immediate ketamine treatment does not prevent posttraumatic stress responses in an animal model for PTSD. Eur neuropsychopharmacology. 2014;24:469\u201379. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.08.007.","journal-title":"Eur neuropsychopharmacology"},{"key":"3979_CR12","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00213-025-06756-4","volume":"242","author":"NJ Wellington","year":"2025","unstructured":"Wellington NJ, Bo\u0173cas AP, Lagopoulos J, Quigley BL, Kuballa AV. Molecular pathways of ketamine: a systematic review of immediate and sustained effects on PTSD. Psychopharmacology. 2025;242:1197\u2013243. https:\/\/doi.org\/10.1007\/s00213-025-06756-4.","journal-title":"Psychopharmacology"},{"key":"3979_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2174\/1570159x22666231027111147","volume":"22","author":"TG Zaretsky","year":"2024","unstructured":"Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, et al. The psychedelic future of post-traumatic stress disorder treatment. Curr Neuropharmacol. 2024;22:636\u2013735. https:\/\/doi.org\/10.2174\/1570159x22666231027111147.","journal-title":"Curr Neuropharmacol"},{"key":"3979_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.36131\/cnfioritieditore20240102","volume":"21","author":"TM Almeida","year":"2024","unstructured":"Almeida TM, Lacerda da Silva UR, Pires JP, Borges IN, Martins CRM, Cordeiro Q, et al. Effectiveness of ketamine for the treatment of post-traumatic stress disorder - a systematic review and meta-analysis. Clin neuropsychiatry. 2024;21:22\u201331. https:\/\/doi.org\/10.36131\/cnfioritieditore20240102.","journal-title":"Clin neuropsychiatry"},{"key":"3979_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.813103","volume":"13","author":"R Du","year":"2022","unstructured":"Du R, Han R, Niu K, Xu J, Zhao Z, Lu G, et al. The multivariate effect of ketamine on PTSD: systematic review and meta-analysis. Front psychiatry. 2022;13:813103. https:\/\/doi.org\/10.3389\/fpsyt.2022.813103.","journal-title":"Front psychiatry"},{"key":"3979_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0829-z","volume":"19","author":"JH Krystal","year":"2017","unstructured":"Krystal JH, Abdallah CG, Averill LA, Kelmendi B, Harpaz-Rotem I, Sanacora G, et al. Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic. Curr psychiatry Rep. 2017;19:74. https:\/\/doi.org\/10.1007\/s11920-017-0829-z.","journal-title":"Curr psychiatry Rep"},{"key":"3979_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238\u201349. https:\/\/doi.org\/10.1038\/nm.4050.","journal-title":"Nat Med"},{"key":"3979_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/neu.2017.39","volume":"30","author":"VS Pereira","year":"2018","unstructured":"Pereira VS, Hiroaki-Sato VA. A brief history of antidepressant drug development: from tricyclics to beyond ketamine. Acta neuropsychiatrica. 2018;30:307\u201322. https:\/\/doi.org\/10.1017\/neu.2017.39.","journal-title":"Acta neuropsychiatrica"},{"key":"3979_CR19","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.neuron.2022.05.001","volume":"110","author":"JP Lopez","year":"2022","unstructured":"Lopez JP, L\u00fccken MD, Brivio E, Karamihalev S, Kos A, De Donno C, et al. Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2. Neuron. 2022;110:2283\u20132298.e2289. https:\/\/doi.org\/10.1016\/j.neuron.2022.05.001.","journal-title":"Neuron"},{"key":"3979_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1523\/jneurosci.3481-08.2009","volume":"29","author":"X Chen","year":"2009","unstructured":"Chen X, Shu S, Bayliss DA. HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine. J Neurosci. 2009;29:600\u20139. https:\/\/doi.org\/10.1523\/jneurosci.3481-08.2009.","journal-title":"J Neurosci"},{"key":"3979_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tacc.2014.03.002","volume":"4","author":"J Sleigh","year":"2014","unstructured":"Sleigh J, Harvey M, Voss L, Denny B. Ketamine \u2013 More mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4:76\u201381. https:\/\/doi.org\/10.1016\/j.tacc.2014.03.002.","journal-title":"Trends Anaesth Crit Care"},{"key":"3979_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/ALN.0b013e318287b7c8","volume":"118","author":"C Zhou","year":"2013","unstructured":"Zhou C, Douglas JE, Kumar NN, Shu S, Bayliss DA, Chen X. Forebrain HCN1 channels contribute to hypnotic actions of ketamine. Anesthesiology. 2013;118:785\u201395. https:\/\/doi.org\/10.1097\/ALN.0b013e318287b7c8.","journal-title":"Anesthesiology"},{"key":"3979_CR23","first-page":"47","volume":"62","author":"S Loix","year":"2011","unstructured":"Loix S, De Kock M, Henin P. The anti-inflammatory effects of ketamine: state of the art. Acta anaesthesiologica Belgica. 2011;62:47\u201358.","journal-title":"Acta anaesthesiologica Belgica"},{"key":"3979_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jad.2019.11.086","volume":"264","author":"FS Correia-Melo","year":"2020","unstructured":"Correia-Melo FS, Leal GC, Vieira F, Jesus-Nunes AP, Mello RP, Magnavita G, et al. Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study. J Affect Disord. 2020;264:527\u201334. https:\/\/doi.org\/10.1016\/j.jad.2019.11.086.","journal-title":"J Affect Disord"},{"key":"3979_CR25","doi-asserted-by":"publisher","first-page":"e12414","DOI":"10.1097\/md.0000000000012414","volume":"97","author":"FS Correia-Melo","year":"2018","unstructured":"Correia-Melo FS, Leal GC, Carvalho MS, Jesus-Nunes AP, Ferreira CBN, Vieira F, et al. Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial. Medicine. 2018;97:e12414 https:\/\/doi.org\/10.1097\/md.0000000000012414.","journal-title":"Medicine"},{"key":"3979_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hup.2475","volume":"30","author":"CM Coyle","year":"2015","unstructured":"Coyle CM, Laws KR. The use of ketamine as an antidepressant: a systematic review and meta-analysis. Hum Psychopharmacol. 2015;30:152\u201363. https:\/\/doi.org\/10.1002\/hup.2475.","journal-title":"Hum Psychopharmacol"},{"key":"3979_CR27","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","volume":"231","author":"G Fond","year":"2014","unstructured":"Fond G, Loundou A, Rabu C, Macgregor A, Lan\u00e7on C, Brittner M, et al. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology. 2014;231:3663\u201376. https:\/\/doi.org\/10.1007\/s00213-014-3664-5.","journal-title":"Psychopharmacology"},{"key":"3979_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1192\/bjp.2019.135","volume":"215","author":"JD Rosenblat","year":"2019","unstructured":"Rosenblat JD. Potential differences in antidepressant effects of oral ketamine liquid suspension versus compounded capsules. Br J psychiatry. 2019;215:434 https:\/\/doi.org\/10.1192\/bjp.2019.135.","journal-title":"Br J psychiatry"},{"key":"3979_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/foods9020194","volume":"9","author":"HS Lee","year":"2020","unstructured":"Lee HS, Kim KH, Park SH, Hur SW, Auh JH. Amylose-Lipid complex as a fat replacement in the preparation of low-fat white pan bread. Foods. 2020;9:194 https:\/\/doi.org\/10.3390\/foods9020194.","journal-title":"Foods"},{"key":"3979_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119725","volume":"588","author":"AC Sintov","year":"2020","unstructured":"Sintov AC. AmyloLipid Nanovesicles: a self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin. Int J pharmaceutics. 2020;588:119725. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119725.","journal-title":"Int J pharmaceutics"},{"key":"3979_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0006-8993(01)02999-7","volume":"919","author":"A Barnea","year":"2001","unstructured":"Barnea A, Roberts J. Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brain-derived neurotrophic factor (BDNF): evidence for a requirement for extracellular-regulated kinase (ERK)-dependent and ERK-independent mechanisms. Brain Res. 2001;919:57\u201369. https:\/\/doi.org\/10.1016\/s0006-8993(01)02999-7.","journal-title":"Brain Res"},{"key":"3979_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/npp.2011.230","volume":"37","author":"H Cohen","year":"2012","unstructured":"Cohen H, Liu T, Kozlovsky N, Kaplan Z, Zohar J, Math\u00e9 AA. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology. 2012;37:350\u201363. https:\/\/doi.org\/10.1038\/npp.2011.230.","journal-title":"Neuropsychopharmacology"},{"key":"3979_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1017\/s1461145707007560","volume":"10","author":"N Kozlovsky","year":"2007","unstructured":"Kozlovsky N, Matar MA, Kaplan Z, Kotler M, Zohar J, Cohen H. Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. Int J neuropsychopharmacology. 2007;10:741\u201358. https:\/\/doi.org\/10.1017\/s1461145707007560.","journal-title":"Int J neuropsychopharmacology"},{"key":"3979_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0840-4","volume":"19","author":"TJ Akiki","year":"2017","unstructured":"Akiki TJ, Averill CL, Abdallah CG. A Network-Based neurobiological model of PTSD: evidence from structural and functional neuroimaging studies. Curr psychiatry Rep. 2017;19:81. https:\/\/doi.org\/10.1007\/s11920-017-0840-4.","journal-title":"Curr psychiatry Rep"},{"key":"3979_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41583-018-0039-7","volume":"19","author":"RJ Fenster","year":"2018","unstructured":"Fenster RJ, Lebois LAM, Ressler KJ, Suh J. Brain circuit dysfunction in post-traumatic stress disorder: from mouse to man. Nat reviews Neurosci. 2018;19:535\u201351. https:\/\/doi.org\/10.1038\/s41583-018-0039-7.","journal-title":"Nat reviews Neurosci"},{"key":"3979_CR36","doi-asserted-by":"publisher","first-page":"17m11634","DOI":"10.4088\/JCP.17m11634","volume":"79","author":"CS Albott","year":"2018","unstructured":"Albott CS, Lim KO, Forbes MK, Erbes C, Tye SJ, Grabowski JG, et al. Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression. J Clin psychiatry. 2018;79:17m11634 https:\/\/doi.org\/10.4088\/JCP.17m11634.","journal-title":"J Clin psychiatry"},{"key":"3979_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101439","volume":"48","author":"H Artin","year":"2022","unstructured":"Artin H, Bentley S, Mehaffey E, Liu FX, Sojourner K, Bismark AW, et al. Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: a retrospective case series. EClinicalMedicine. 2022;48:101439. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101439.","journal-title":"EClinicalMedicine"},{"key":"3979_CR38","doi-asserted-by":"publisher","unstructured":"Cohen, H, Matar, MA & Joseph, Z Animal models of post-traumatic stress disorder. Current protocols in neuroscience Chapter 9, Unit 945, 2013. https:\/\/doi.org\/10.1002\/0471142301.ns0945s64.","DOI":"10.1002\/0471142301.ns0945s64"},{"key":"3979_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1196\/annals.1314.014","volume":"1032","author":"H Cohen","year":"2004","unstructured":"Cohen H, Zohar J. An animal model of posttraumatic stress disorder: the use of cut-off behavioral criteria. Ann N Y Acad Sci. 2004;1032:167\u201378. https:\/\/doi.org\/10.1196\/annals.1314.014.","journal-title":"Ann N Y Acad Sci"},{"key":"3979_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0006-3223(02)01909-1","volume":"53","author":"H Cohen","year":"2003","unstructured":"Cohen H, Zohar J, Matar M. The relevance of differential response to trauma in an animal model of posttraumatic stress disorder. Biol psychiatry. 2003;53:463\u201373. https:\/\/doi.org\/10.1016\/s0006-3223(02)01909-1.","journal-title":"Biol psychiatry"},{"key":"3979_CR41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuropharm.2011.04.023","volume":"62","author":"H Cohen","year":"2012","unstructured":"Cohen H, Kozlovsky N, Alona C, Matar MA, Joseph Z. Animal model for PTSD: from clinical concept to translational research. Neuropharmacology. 2012;62:715\u201324. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.04.023.","journal-title":"Neuropharmacology"},{"key":"3979_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.116945","volume":"264","author":"Z Yang","year":"2025","unstructured":"Yang Z, Li L, Deng B, Xu Y, Du Y, Lv Y, et al. Pharmacokinetics and brain distribution of ketamine after nasal administration. J Pharm Biomed Anal. 2025;264:116945. https:\/\/doi.org\/10.1016\/j.jpba.2025.116945.","journal-title":"J Pharm Biomed Anal"},{"key":"3979_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109357","volume":"225","author":"TML Nguyen","year":"2023","unstructured":"Nguyen TML, Defaix C, Mendez-David I, Tritschler L, Etting I, Alvarez JC, et al. Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory\/inhibitory synaptic activity. Neuropharmacology. 2023;225:109357. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109357.","journal-title":"Neuropharmacology"},{"key":"3979_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","volume":"181","author":"L Chang","year":"2019","unstructured":"Chang L, Zhang K, Pu Y, Qu Y, Wang SM, Xiong Z, et al. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacology, biochemistry, Behav. 2019;181:53\u201359. https:\/\/doi.org\/10.1016\/j.pbb.2019.04.008.","journal-title":"Pharmacology, biochemistry, Behav"},{"key":"3979_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpsychires.2019.02.003","volume":"112","author":"V Naidoo","year":"2019","unstructured":"Naidoo V, Mdanda S, Ntshangase S, Naicker T, Kruger HG, Govender T, et al. Brain penetration of ketamine: intranasal delivery VS parenteral routes of administraion. J Psychiatr Res. 2019;112:7\u201311. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.02.003.","journal-title":"J Psychiatr Res"},{"key":"3979_CR46","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/npp.2014.257","volume":"40","author":"S Cohen","year":"2015","unstructured":"Cohen S, Vainer E, Matar MA, Kozlovsky N, Kaplan Z, Zohar J, et al. Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times. Neuropsychopharmacology. 2015;40:774\u201390. https:\/\/doi.org\/10.1038\/npp.2014.257.","journal-title":"Neuropsychopharmacology"},{"key":"3979_CR47","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.biopsych.2005.04.002","volume":"58","author":"H Cohen","year":"2005","unstructured":"Cohen H, Zohar J, Matar MA, Kaplan Z, Geva AB. Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol psychiatry. 2005;58:640\u201350. https:\/\/doi.org\/10.1016\/j.biopsych.2005.04.002.","journal-title":"Biol psychiatry"},{"key":"3979_CR48","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/sj.npp.1300523","volume":"29","author":"H Cohen","year":"2004","unstructured":"Cohen H, Zohar J, Matar MA, Zeev K, Loewenthal U, Richter-Levin G. Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology. 2004;29:1962\u201370. https:\/\/doi.org\/10.1038\/sj.npp.1300523.","journal-title":"Neuropsychopharmacology"},{"key":"3979_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0165-0270(97)00163-5","volume":"79","author":"R Gibb","year":"1998","unstructured":"Gibb R, Kolb B. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci methods. 1998;79:1\u20134. https:\/\/doi.org\/10.1016\/s0165-0270(97)00163-5.","journal-title":"J Neurosci methods"},{"key":"3979_CR50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","volume":"10","author":"L Li","year":"2016","unstructured":"Li L, Vlisides PE. Ketamine: 50 years of modulating the mind. Front Hum Neurosci. 2016;10:612 https:\/\/doi.org\/10.3389\/fnhum.2016.00612.","journal-title":"Front Hum Neurosci"},{"key":"3979_CR51","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.biopsych.2017.12.007","volume":"84","author":"K Hashimoto","year":"2018","unstructured":"Hashimoto K, Shirayama Y. What are the causes for discrepancies of antidepressant actions of (2R,6R)-Hydroxynorketamine?. Biol psychiatry. 2018;84:e7\u2013e8. https:\/\/doi.org\/10.1016\/j.biopsych.2017.12.007.","journal-title":"Biol psychiatry"},{"key":"3979_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.026","volume":"100","author":"MJ Girgenti","year":"2017","unstructured":"Girgenti MJ, Ghosal S, LoPresto D, Taylor JR, Duman RS. Ketamine accelerates fear extinction via mTORC1 signaling. Neurobiol Dis. 2017;100:1\u20138. https:\/\/doi.org\/10.1016\/j.nbd.2016.12.026.","journal-title":"Neurobiol Dis"},{"key":"3979_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2017.08.026","volume":"658","author":"L Saur","year":"2017","unstructured":"Saur L, Neves LT, Greggio S, Venturin GT, Jeckel CMM, Costa Da Costa J, et al. Ketamine promotes increased freezing behavior in rats with experimental PTSD without changing brain glucose metabolism or BDNF. Neurosci Lett. 2017;658:6\u201311. https:\/\/doi.org\/10.1016\/j.neulet.2017.08.026.","journal-title":"Neurosci Lett"},{"key":"3979_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0310-8","volume":"8","author":"KD Radford","year":"2018","unstructured":"Radford KD, Park TY, Jaiswal S, Pan H, Knutsen A, Zhang M, et al. Enhanced fear memories and brain glucose metabolism ((18)F-FDG-PET) following sub-anesthetic intravenous ketamine infusion in Sprague-Dawley rats. Transl psychiatry. 2018;8:263. https:\/\/doi.org\/10.1038\/s41398-018-0310-8.","journal-title":"Transl psychiatry"},{"key":"3979_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112259","volume":"378","author":"KD Radford","year":"2020","unstructured":"Radford KD, Spencer HF, Zhang M, Berman RY, Girasek QL, Choi KH. Association between intravenous ketamine-induced stress hormone levels and long-term fear memory renewal in Sprague-Dawley rats. Behavioural brain Res. 2020;378:112259. https:\/\/doi.org\/10.1016\/j.bbr.2019.112259.","journal-title":"Behavioural brain Res"},{"key":"3979_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fnbeh.2018.00229","volume":"12","author":"Y Yang","year":"2018","unstructured":"Yang Y, Ju W, Zhang H, Sun L. Effect of Ketamine on LTP and NMDAR EPSC in hippocampus of the chronic social defeat stress mice model of depression. Front Behav Neurosci. 2018;12:229 https:\/\/doi.org\/10.3389\/fnbeh.2018.00229.","journal-title":"Front Behav Neurosci"},{"key":"3979_CR57","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.euroneuro.2014.09.009","volume":"24","author":"H Cohen","year":"2014","unstructured":"Cohen H, Kozlovsky N, Matar MA, Zohar J, Kaplan Z. Distinctive hippocampal and amygdalar cytoarchitectural changes underlie specific patterns of behavioral disruption following stress exposure in an animal model of PTSD. Eur neuropsychopharmacology. 2014;24:1925\u201344. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.09.009.","journal-title":"Eur neuropsychopharmacology"},{"key":"3979_CR58","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nn962","volume":"5","author":"A L\u00f6rincz","year":"2002","unstructured":"L\u00f6rincz A, Notomi T, Tam\u00e1s G, Shigemoto R, Nusser Z. Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites. Nat Neurosci. 2002;5:1185\u201393. https:\/\/doi.org\/10.1038\/nn962.","journal-title":"Nat Neurosci"},{"key":"3979_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/cne.11039","volume":"471","author":"T Notomi","year":"2004","unstructured":"Notomi T, Shigemoto R. Immunohistochemical localization of Ih channel subunits, HCN1-4, in the rat brain. J Comp Neurol. 2004;471:241\u201376. https:\/\/doi.org\/10.1002\/cne.11039.","journal-title":"J Comp Neurol"},{"key":"3979_CR60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.neuron.2012.05.027","volume":"75","author":"CS Kim","year":"2012","unstructured":"Kim CS, Chang PY, Johnston D. Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors. Neuron. 2012;75:503\u201316. https:\/\/doi.org\/10.1016\/j.neuron.2012.05.027.","journal-title":"Neuron"},{"key":"3979_CR61","doi-asserted-by":"publisher","first-page":"16970","DOI":"10.1523\/jneurosci.2306-10.2010","volume":"30","author":"CJ Giesbrecht","year":"2010","unstructured":"Giesbrecht CJ, Mackay JP, Silveira HB, Urban JH, Colmers WF. Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J Neurosci. 2010;30:16970\u201382. https:\/\/doi.org\/10.1523\/jneurosci.2306-10.2010.","journal-title":"J Neurosci"},{"key":"3979_CR62","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1038\/s41380-022-01682-9","volume":"27","author":"J Kim","year":"2022","unstructured":"Kim J, Lei Y, Lu XY, Kim CS. Glucocorticoid-glucocorticoid receptor-HCN1 channels reduce neuronal excitability in dorsal hippocampal CA1 neurons. Mol psychiatry. 2022;27:4035\u201349. https:\/\/doi.org\/10.1038\/s41380-022-01682-9.","journal-title":"Mol psychiatry"},{"key":"3979_CR63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/350230a0","volume":"350","author":"C Hyman","year":"1991","unstructured":"Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991;350:230\u20132. https:\/\/doi.org\/10.1038\/350230a0.","journal-title":"Nature"},{"key":"3979_CR64","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1523\/jneurosci.3528-17.2018","volume":"38","author":"H Silveira Villarroel","year":"2018","unstructured":"Silveira Villarroel H, Bompolaki M, Mackay JP, Miranda Tapia AP, Michaelson SD, Leitermann RJ, et al. NPY Induces stress resilience via downregulation of I(h) in principal neurons of rat basolateral amygdala. J Neurosci. 2018;38:4505\u201320. https:\/\/doi.org\/10.1523\/jneurosci.3528-17.2018.","journal-title":"J Neurosci"},{"key":"3979_CR65","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41593-022-01146-x","volume":"25","author":"P Georgiou","year":"2022","unstructured":"Georgiou P, Zanos P, Mou TM, An X, Gerhard DM, Dryanovski DI, et al. Experimenters\u2019 sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor. Nat Neurosci. 2022;25:1191\u20131200. https:\/\/doi.org\/10.1038\/s41593-022-01146-x.","journal-title":"Nat Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03979-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03979-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03979-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:02:26Z","timestamp":1775070146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03979-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3979"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03979-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}